16
Jan
2019

Big Money For Glaring Global Health Needs: George Scangos on The Long Run

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more.

 
 

You may also like

Innate Immune System Activators for Cancer: Art Krieg on The Long Run
Creating a New Class of Medicines: Eric Fischer on The Long Run
A Song of Science and Hope: Bruce Levine & Mags McCarthy on The Long Run
Predicting Leukemia Risk At Scale: Dr. Lachelle Weeks on The Long Run